| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $16.0M | +855.2% | +0.0% |
| SG&A Expense | $1.5M | +30.8% | +4.9% |
| Operating Income | -$2.9M | -2.8% | +18.7% |
| Interest Expense | $5K | +150.0% | -16.7% |
| Net Income | -$2.9M | -3.0% | +17.8% |
| EPS (Basic) | -$0.38 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.2M | -3.5% | -35.0% |
| Current Assets | $6.8M | +5.9% | -23.0% |
| Total Assets | $7.0M | +4.6% | -25.3% |
| Current Liabilities | $3.5M | -12.4% | +29.7% |
| Total Liabilities | $3.8M | -7.1% | +37.9% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.7M | — | — |
| Financing Cash Flow | $3.1M | — | — |
| +83.6% |
| EPS (Diluted) | -$0.38 | +34.5% | +83.6% |
| $3.2M |
| +22.6% |
| -51.4% |